323990 — Vaxcell Bio Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Vaxcell Bio Therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8,074	18,903	27,309	20,392	50,046
Net Total Accounts Receivable
Net Total Receivables	120	112	374	291	715
Total Inventory
Prepaid Expenses
Total Current Assets	8,317	19,186	28,197	20,898	51,227
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,557	1,142	2,804	2,541	2,674
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	10,036	35,498	31,276	24,163	84,980
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	426	594	392	307	924
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	964	830	1,196	836	1,487
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Total Equity	9,071	34,667	30,080	23,327	83,493
Total Liabilities & Shareholders' Equity	10,036	35,498	31,276	24,163	84,980
Total Common Shares Outstanding